Application of Machine Learning and Mechanistic Modeling to Predict Intravenous Pharmacokinetic Profiles in Humans
Xuelian Jia1,2, Donato Teutonico3, Saroj Dhakal4
1Center for Biomedical Informatics and Genomics, Tulane University, New Orleans, Louisiana 70112, United States.
Machine learning models predict human pharmacokinetics (PK) for drug discovery. These data-driven approaches offer accurate predictions, improving early drug screening and design.
Area of Science:
- Pharmacology
- Computational Chemistry
- Drug Discovery
Background:
- Accurate prediction of human pharmacokinetics (PK) is vital for efficient drug discovery.
- Traditional PK prediction methods (allometric scaling, mechanistic modeling) are resource-intensive and raise ethical concerns due to reliance on in vitro/in vivo data.
- Machine learning (ML) offers a data-driven alternative to overcome these limitations.
Purpose of the Study:
- To develop and validate novel machine learning frameworks for predicting human pharmacokinetic profiles.
- To leverage a comprehensive dataset of small molecules' physicochemical and PK properties, including digitized human plasma concentration-time profiles.
- To enhance early molecular screening and design in the drug discovery pipeline.
Main Methods:
- Compiled a large dataset of small molecule physicochemical and PK properties from public sources.
- Digitized human plasma concentration-time profiles for approximately 800 compounds.
- Developed and applied a hybrid modeling framework combining ML with physiologically based pharmacokinetic modeling.
- Utilized a hierarchical ML framework with two learning steps for direct PK profile estimation.
Main Results:
- The developed ML frameworks achieved prediction accuracies within 2-fold error for 40-60% of compounds and 5-fold error for 80-90% of compounds for both AUC and Cmax.
- The models were validated on a set of 106 drugs.
- Demonstrated the capability of data-driven models to accurately predict key PK parameters.
Conclusions:
- The proposed hybrid and hierarchical ML frameworks provide accurate and efficient methods for predicting human pharmacokinetic profiles.
- These data-driven approaches can significantly enhance early-stage molecular screening and design in drug discovery.
- The study advances computational capabilities for drug development, potentially reducing costs and timelines.
Related Concept Videos
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Mechanistic Models: Overview of Compartment Models
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Model Approaches for Pharmacokinetic Data: Compartment Models
Two primary types of compartment models are recognized: mammillary and catenary. The more...


